Short and Long-Term Safety of MP29-02*: A New Therapy for the Treatment of Allergic Rhinitis
Clinical and Translational Allergy - United Kingdom
doi 10.1186/2045-7022-3-s2-o15
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC